IBN Announces Latest Episode of The BioMedWire Podcast Featuring Giorgio R. Saumat, CEO of Earth Science Tech Inc.
MWN-AI** Summary
IBN has recently released the latest episode of The BioMedWire Podcast, featuring an insightful discussion with Giorgio R. Saumat, Chairman and CEO of Earth Science Tech Inc. (OTC: ETST). This episode aligns with IBN’s commitment to connect public companies with the investment community through specialized content dissemination.
In the interview, Saumat delineates Earth Science Tech’s business strategy as a strategic holding company focused on healthcare, particularly in compounding pharmaceuticals and telehealth. He emphasizes the organization’s goal to create a vertically integrated healthcare company, leveraging subsidiaries such as Peaks Curative for online telehealth services and Mister Meds along with RxCompoundStore.com for medication fulfillment.
Saumat elaborates on the company’s financial discipline, highlighting its cash flow positivity and robust balance sheet—attributes that are rare among OTC companies. He notes that Earth Science Tech has not needed to access capital markets in the last three years and is now preparing for a potential uplist, anticipating increased liquidity as the market becomes more acquainted with the company’s story.
Further, Saumat discusses the company's profitability and diversification efforts made in 2025, expressing confidence in sector growth throughout 2026. With a nimble operational structure, Earth Science Tech is poised to scale its business effectively in a competitive market.
Listeners are encouraged to join Carmel Fisher as she interviews Saumat to gain deeper insights into the company’s growth trajectory, financial strength, and commitment to scalability. The episode underscores IBN's mission to expand its network and provide impactful corporate messaging solutions to a myriad of public and private companies. For episode access and subscription details, visit the podcast's website.
MWN-AI** Analysis
Earth Science Tech Inc. (OTC: ETST) is positioning itself as a compelling investment opportunity based on its latest podcast interview featuring CEO Giorgio R. Saumat. ETST operates a vertically integrated healthcare business model that encompasses compounding pharmaceuticals and telehealth services, ensuring a comprehensive approach to patient care.
One key takeaway from Saumat's remarks is the company’s strong financial footing. ETST's ability to remain cash flow positive while avoiding capital market dependence for the past three years sets it apart from many OTC competitors. A robust balance sheet with little to no debt gives the company leverage for growth and the potential for an uplist to a senior exchange, which could increase visibility and liquidity for investors.
Moreover, ETST’s diversification strategy, highlighted by its subsidiaries like Peaks Curative and its compounding pharmacies, indicates a commitment to scaling its operations. The CEO stated that the company has already made successful diversification moves in 2025, which it plans to build upon in the upcoming year. This proactive stance could lead to additional revenue streams and a stronger overall market presence.
However, with all investments comes risk, particularly in the biotech and telehealth sectors, where regulatory environments and market dynamics can impact growth trajectories. Investors should stay updated on the company’s developments and industry trends.
In conclusion, Earth Science Tech Inc. exemplifies a potentially strategic investment choice for those seeking exposure to healthcare innovation, driven by solid fundamentals and growth prospects. Keep an eye on ETST’s upcoming milestones as it continues to execute its growth strategy and move towards a planned uplisting. Be sure to listen to the full podcast for a deeper understanding of ETST's business model and future outlook.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
AUSTIN, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancement. The latest episode features Giorgio R. Saumat, Chairman and CEO of Earth Science Tech Inc. (OTC: ETST), a strategic holding company focused on acquiring and scaling high-potential operating businesses.
To begin the interview, Saumat outlined Earth Science Tech’s core business model and how the company has structured its healthcare operations.
“Earth Science Tech, at this time, is a strategic holding company with core assets in healthcare, mostly compounding pharmaceuticals and online telehealth,” he said. “We are creating a vertically integrated healthcare company. From the marketing side we have Peaks Curative, our online telehealth subsidiary, all the way through Mister Meds and RxCompoundStore.com that fulfill the patient.”
He then discussed the company’s financial discipline and capital markets positioning, emphasizing its balance sheet strength and preparation for a potential uplist.
“We have not had any need to tap the capital markets in the last three years. The company is strong on a cash flow basis and has a very strong balance sheet… There are not many OTC companies that are cash flow positive with positive EPS and a strong balance sheet as we have. We have very little debt. We’re preparing the company for a proper uplist, and I think that’s going to help with our liquidity as the market finally gets to know who we are and gets our story out.”
Looking ahead, Saumat highlighted the company’s profitability, diversification strategy and readiness to scale.
“We are a profitable company, and our earnings and revenue are growing. We made some diversification moves in 2025, and I think we’re going to be building on those throughout the rest of 2026… There are a lot of companies out there much larger than we are that wish they could be in the position that we’re in. Luckily, we’re small and nimble, so we were able to put it together. Now it’s time to scale it, which is what we’re headed toward.”
Join IBN’s Carmel Fisher for a conversation with Giorgio R. Saumat, Chairman and CEO of Earth Science Tech, as he discusses the company’s vertically integrated healthcare model, financial strength and pathway toward scaled growth.
To hear the episode and subscribe for future podcasts, visit https://podcast.biomedwire.com
The latest installment of The BioMedWire Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 20 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.
To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine
About Earth Science Tech Inc.
Earth Science Tech Inc. is a diversified holding company focused on the health and wellness sector. Through its wholly-owned subsidiaries, ETST operates a vertically integrated portfolio that includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. The company currently owns RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states. These operations are supported by Peaks Curative and Doconsultation.com, telemedicine platforms that connect patients with providers for personalized care.
Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and MagneChef, a direct-to-consumer brand leveraging proprietary IP for innovative kitchen products. The company is also committed to social responsibility through the Earth Science Foundation, a non-profit dedicated to assisting patients with prescription costs.
For more information, visit the company’s website at www.EarthScienceTech.com
About IBN
IBN consists of financial brands introduced to the investment public over the course of 20+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
FAQ**
How does Earth Science Tech Inc (ETST) plan to leverage its strong balance sheet and cash flow position to facilitate an uplisting in the near future?
What specific diversification moves did Earth Science Tech Inc (ETST) implement in 20that are expected to contribute to its growth throughout 2026?
Can you elaborate on the vertical integration strategy of Earth Science Tech Inc (ETST) and how it enhances the company’s competitive advantage in the healthcare market?
What role does the Earth Science Foundation play in Earth Science Tech Inc (ETST)'s commitment to social responsibility, and how does it align with the company's overall business strategy?
**MWN-AI FAQ is based on asking OpenAI questions about Earth Science Tech Inc (OTC: ETST).
NASDAQ: ETST
ETST Trading
-8.48% G/L:
$0.1079 Last:
3,000 Volume:
$0.109433 Open:
